Last update 21 Nov 2024

Zanzalintinib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Zanzalintinib Fumarate
+ [1]
Mechanism
AXL inhibitors(AXL receptor tyrosine kinase inhibitors), MerTK inhibitors(Tyrosine-protein kinase Mer inhibitors), VEGFR1 antagonists(Vascular endothelial growth factor receptor 1 antagonists)
+ [1]
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC29H25FN4O5
InChIKeyJSPCKALGNNVYOO-UHFFFAOYSA-N
CAS Registry2367004-54-2

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic Colorectal CarcinomaPhase 3
TW
07 Sep 2022
Metastatic Colorectal CarcinomaPhase 3
PL
07 Sep 2022
Metastatic Colorectal CarcinomaPhase 3
HU
07 Sep 2022
Metastatic Colorectal CarcinomaPhase 3
ES
07 Sep 2022
Metastatic Colorectal CarcinomaPhase 3
AU
07 Sep 2022
Metastatic Colorectal CarcinomaPhase 3
BE
07 Sep 2022
Metastatic Colorectal CarcinomaPhase 3
GB
07 Sep 2022
Metastatic Colorectal CarcinomaPhase 3
NZ
07 Sep 2022
Metastatic Colorectal CarcinomaPhase 3
KR
07 Sep 2022
Metastatic Colorectal CarcinomaPhase 3
DE
07 Sep 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
Renal Cell Carcinoma
VEGF | GAS6 | ANG-1 ...
32
(fnauojoynq) = hxfqktsaqn paqcqjsqgt (vjeubapwtu )
Positive
24 May 2024
Phase 1
32
(njnnqmwipx) = rxzhozaplr ghjasanegd (isfzwqqdil )
Positive
10 Nov 2023
(tziwasgmmi) = kaepcjzdno imfxwsjvzb (uetgrpdbjb )
Phase 1
73
(SA)
(qovkcwaepf) = ngcabyvjxe kaqmxnwose (utameayghm )
Positive
10 Sep 2022
(qovkcwaepf) = pczjewtqkm kaqmxnwose (utameayghm )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free